Abstract The SYNCHRONY protocol represents a structured, four-week, lifestyle-medicine framework designed for the restoration of female hormonal homeostasis through the convergence of circadian biology, Ayurgenomics, chrono-nutrition, and sensory neuro-modulation. The protocol operates on the Evolutionary Mismatch Hypothesis, proposing that modern endocrine dysfunction—including PCOS and functional hypothalamic amenorrhea (FHA)—results from the discordance between the Pleistocene genome and the contemporary technological environment. Core Methodology The protocol integrates eight evidence-anchored domains into a phased, patient-centered intervention: Circadian Entrainment: utilization of morning phototherapy to reset the suprachiasmatic nucleus (SCN) and normalize the Cortisol Awakening Response Ayurgenomics Phenotypic Stratification: application of Ayurvedic constitutional typology (Prakriti) as a precision-medicine tool to stratify metabolic and endocrine vulnerabilities (Vata, Pitta, Kapha). Chrono-nutrition: implementation of dosha-specific dietary frameworks, including early time-restricted feeding (eTRF) to align caloric intake with metabolic and insulin-secretory peaks. Differentiated Biological Movement: prescription of exercise modalities aligned with Prakriti-specific HPO-axis vulnerabilities to modulate AMPK activity and insulin sensitivity. Clinical Implementation Roadmap The protocol is executed in a stepwise, four-week architectural progression: Week 1 (Circadian Reset): stabilization of pineal and follicular melatonin secretion via light hygiene. Week 2 (Sensory Neuro-modulation): downregulation of neurogenic inflammation through tactile and olfactory cues. Week 3 (Metabolic Integration): optimization of insulin sensitivity and mitochondrial efficiency via chrono-nutrition. Week 4 (Epigenetic Stabilization): consolidation of systemic resilience and GnRH pulsatility. Disclaimer and Scope of Responsibility The SYNCHRONY protocol is intended strictly as a lifestyle-medicine adjunct within an integrated care model. The following conditions apply to its use: Clinical Validation and Oversight: this protocol must be validated and implemented under the strict observation and continuous supervision of a licensed physician, gynecologist, endocrinologist, or authorized clinical institution. It is not designed for self-administration without professional medical clearance. Methodological Limitation: the scope of this document is limited exclusively to the conceptualization, theoretical design, and structural methodology of the SYNCHRONY framework. Medical Disclaimer: this protocol does not constitute a medical prescription and is not a replacement for pharmacological or surgical management of endocrine pathology. The integration of any phytotherapeutic or nutritional intervention must be screened for herb-drug interactions by a qualified clinician. Liability: the author accepts no clinical liability for health outcomes, diagnostic interpretations, or therapeutic consequences arising from the implementation of this protocol by third parties. Responsibility for patient safety, ongoing monitoring, and the assessment of individual contraindications—including pregnancy, breastfeeding, or concurrent hormonal/anticoagulant pharmacotherapy—lies solely with the supervising medical professional or institution.
V. Luongo (Tue,) studied this question.